메뉴 건너뛰기




Volumn 16, Issue 3, 2012, Pages 105-112

Molecular pathways and crosstalk characterizing the cardiorenal syndrome

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADIPOCYTOKINE RECEPTOR; ALBUMIN; APOLIPOPROTEIN A1; ARACHIDONIC ACID; CHEMOKINE RECEPTOR; CYTOKINE; GLUTATHIONE; GLYCOSAMINOGLYCAN; HISTIDINE; ISOLEUCINE; LEUCINE; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PURINE; TERPENOID; THIOCTIC ACID; TYROSINE; VALINE; VASOPRESSIN;

EID: 84859801582     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2011.0121     Document Type: Article
Times cited : (16)

References (43)
  • 2
    • 40749121688 scopus 로고    scopus 로고
    • The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment
    • DOI 10.1111/j.1463-1326.2007.00714.x
    • Andrikoula, M., and McDowell, I.F.W. (2008). The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment. Diabetes Obes Metab 10, 271-278 (Pubitemid 351386024)
    • (2008) Diabetes, Obesity and Metabolism , vol.10 , Issue.4 , pp. 271-278
    • Andrikoula, M.1    Mcdowell, I.F.W.2
  • 5
    • 33846031473 scopus 로고    scopus 로고
    • Kidney-heart interactions: Epidemiology, pathogenesis, and treatment
    • Berl, T., and Henrich, W. (2006). Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 1, 8-18
    • (2006) Clin. J. Am. Soc. Nephrol. , vol.1 , pp. 8-18
    • Berl, T.1    Henrich, W.2
  • 7
    • 0030512150 scopus 로고    scopus 로고
    • Transforming growth factor β in diabetic nephropathy
    • DOI 10.1002/(SICI)1099-0895(199612)12:4<309::AID-DMR171>3.0.CO;2-A
    • Border, W.A., Yamamoto, T., and Noble, N.A. (1996). Transforming growth factor beta in diabetic nephropathy. Diabetes Metab Rev 12, 309-339 (Pubitemid 27062225)
    • (1996) Diabetes/Metabolism Reviews , vol.12 , Issue.4 , pp. 309-339
    • Border, W.A.1    Yamamoto, T.2    Noble, N.A.3
  • 8
    • 41449096186 scopus 로고    scopus 로고
    • Increased expression of light/ tnfsf14 and its receptors in experimental and clinical heart failure
    • Dahl, C.P., Gullestad, L., Fevang, B., Holm, A.M., Landrø, L., Vinge, L.E., et al.. (2008). Increased expression of LIGHT/ TNFSF14 and its receptors in experimental and clinical heart failure. Eur J Heart Failure 10, 352-359
    • (2008) Eur. J. Heart Failure. , vol.10 , pp. 352-359
    • Dahl, C.P.1    Gullestad, L.2    Fevang, B.3    Holm, A.M.4    Landrø, L.5    Vinge, L.E.6
  • 11
    • 0032731318 scopus 로고    scopus 로고
    • The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?
    • DOI 10.1046/j.1523-1755.1999.00721.x
    • Gilbert, R.E., and Cooper, M.E. (1999). The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 56, 1627-1637 (Pubitemid 29518163)
    • (1999) Kidney International , vol.56 , Issue.5 , pp. 1627-1637
    • Gilbert, R.E.1    Cooper, M.E.2
  • 12
    • 0015110675 scopus 로고
    • Relationship of cardiorenal function to renin-aldosterone system in patients with valvular heart disease
    • Judson, W.E., and Helmer, O.M. (1971). Relationship of cardiorenal function to renin-aldosterone system in patients with valvular heart disease. Circulation 44, 245-253
    • (1971) Circulation , vol.44 , pp. 245-253
    • Judson, W.E.1    Helmer, O.M.2
  • 13
    • 0033982936 scopus 로고    scopus 로고
    • KEGG: Kyoto encyclopedia of genes and genomes
    • Kanehisa, M., and Goto, S. (2000). KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28, 27-30 (Pubitemid 30047706)
    • (2000) Nucleic Acids Research , vol.28 , Issue.1 , pp. 27-30
    • Kanehisa, M.1    Goto, S.2
  • 14
    • 30944466704 scopus 로고    scopus 로고
    • Overview of hemostatic factors involved in atherosclerotic cardiovascular disease
    • DOI 10.1007/s11745-005-1488-8, L9745
    • Kannel, W.B. (2005). Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 40, 1215-1220 (Pubitemid 43117845)
    • (2005) Lipids , vol.40 , Issue.12 , pp. 1215-1220
    • Kannel, W.B.1
  • 16
    • 0030721722 scopus 로고    scopus 로고
    • Fibrinogen and fibrinolytic activity in CAPD patients with atherosclerosis and its correlation with serum albumin
    • Kim, K.J., Yang, W.S., Kim, S.B., Lee, S.K., and Park, J.S. (1997). Fibrinogen and fibrinolytic activity in CAPD patients with atherosclerosis and its correlation with serum albumin. Peritoneal Dial Int 17, 157-161 (Pubitemid 27474772)
    • (1997) Peritoneal Dialysis International , vol.17 , Issue.2 , pp. 157-161
    • Kim, K.J.1    Yang, W.S.2    Kim, S.B.3    Lee, S.K.4    Park, J.S.5
  • 17
    • 32044449192 scopus 로고    scopus 로고
    • Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis
    • Kirmizis, D., Tsiandoulas, A., Pangalou, M., Koutoupa, E., Rozi, P., Protopappa, M., et al.. (2006). Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis. Med Sci Monitor 12, CR55-CR62 (Pubitemid 43200944)
    • (2006) Medical Science Monitor , vol.12 , Issue.2
    • Kirmizis, D.1    Tsiandoulas, A.2    Pangalou, M.3    Koutoupa, E.4    Rozi, P.5    Protopappa, M.6    Barboutis, K.7
  • 22
    • 0016403709 scopus 로고
    • Accelerated atherosclerosis in prolonged maintenance hemodialysis
    • Lindner, A., Charra, B., Sherrard, D.J., and Scribner, B.H. (1974). Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290, 697-701
    • (1974) N. Engl. J. Med. , vol.290 , pp. 697-701
    • Lindner, A.1    Charra, B.2    Sherrard, D.J.3    Scribner, B.H.4
  • 23
    • 70149118042 scopus 로고    scopus 로고
    • Antihypertensive pharmacogenetic effect of fibrinogen-beta variant - 455G >A on cardiovascular disease, end-stage renal disease, and mortality: The genhat study
    • Lynch, A.I., Boerwinkle, E., Davis, B.R., Ford, C.E., Eckfeldt, J.H., Leiendecker-Foster, C., et al.. (2009). Antihypertensive pharmacogenetic effect of fibrinogen-beta variant - 455G >A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study. Pharmacogenet Genomics 19, 415-421
    • (2009) Pharmacogenet Genomics , vol.19 , pp. 415-421
    • Lynch, A.I.1    Boerwinkle, E.2    Davis, B.R.3    Ford, C.E.4    Eckfeldt, J.H.5    Leiendecker-Foster, C.6
  • 24
    • 77950342584 scopus 로고    scopus 로고
    • Cardiorenal interaction: Appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease
    • McCullough, P.A., and Verrill, T.A. (2010). Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease. Postgrad Med 122, 25-34
    • (2010) Postgrad. Med. , vol.122 , pp. 25-34
    • Mc Cullough, P.A.1    Verrill, T.A.2
  • 25
    • 0033563007 scopus 로고    scopus 로고
    • Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation
    • Mitchell, D.A., Taylor, P.R., Cook, H.T., Moss, J., Bygrave, A.E., Walport, M.J., et al.. (1999). Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation. J Immunol 162, 5676-5679 (Pubitemid 29314916)
    • (1999) Journal of Immunology , vol.162 , Issue.10 , pp. 5676-5679
    • Mitchell, D.A.1    Taylor, P.R.2    Cook, H.T.3    Moss, J.4    Bygrave, A.E.5    Walport, M.J.6    Botto, M.7
  • 26
    • 33751192457 scopus 로고    scopus 로고
    • Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: The AtheroGene study
    • Morange, P.E., Bickel, C., Nicaud, V., Schnabel, R., Rupprecht, H.J., Peetz, D., et al.. (2006). Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol 26, 2793-2799
    • (2006) Arterioscler Thromb. Vasc. Biol. , vol.26 , pp. 2793-2799
    • Morange, P.E.1    Bickel, C.2    Nicaud, V.3    Schnabel, R.4    Rupprecht, H.J.5    Peetz, D.6
  • 27
  • 28
    • 0031706340 scopus 로고    scopus 로고
    • The tubulointerstitium in progressive renal disease
    • DOI 10.1046/j.1523-1755.1998.00079.x
    • Nath, K.A. (1998). The tubulointerstitium in progressive renal disease. Kidney Int 54, 992-994 (Pubitemid 28397421)
    • (1998) Kidney International , vol.54 , Issue.3 , pp. 992-994
    • Nath, K.A.1
  • 29
    • 77952834144 scopus 로고    scopus 로고
    • Linking transcriptomic and proteomic data on the level of protein interaction networks
    • Perco, P., Mühlberger, I., Mayer, G., Oberbauer, R., Lukas, A., and Mayer, B. (2010). Linking transcriptomic and proteomic data on the level of protein interaction networks. Electrophoresis 31, 1780-1789
    • (2010) Electrophoresis , vol.31 , pp. 1780-1789
    • Perco, P.1    Mühlberger, I.2    Mayer, G.3    Oberbauer, R.4    Lukas, A.5    Mayer, B.6
  • 31
    • 77954601208 scopus 로고    scopus 로고
    • Cardiorenal syndromes: An executive summary from the consensus conference of the acute dialysis quality initiative (adqi
    • Ronco, C., McCullough, P.A., Anker, S.D., Anand, I., Aspromonte, N., Bagshaw, S.M., et al.. (2010). Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 165, 54-67
    • (2010) Contrib Nephrol , vol.165 , pp. 54-67
    • Ronco, C.1    Mc Cullough, P.A.2    Anker, S.D.3    Anand, I.4    Aspromonte, N.5    Bagshaw, S.M.6
  • 32
    • 0022825988 scopus 로고
    • The epidemiology of coronary artery disease in patients on maintenance hemodialysis: Implications for management
    • Rostand, S.G., Kirk, K.A., and Rutsky, E.A. (1986). The epidemiology of coronary artery disease in patients on maintenance hemodialysis: implications for management. Contrib Nephrol 52, 34-41
    • (1986) Contrib Nephrol , vol.52 , pp. 34-41
    • Rostand, S.G.1    Kirk, K.A.2    Rutsky, E.A.3
  • 33
    • 34548624338 scopus 로고    scopus 로고
    • Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men
    • DOI 10.1016/j.atherosclerosis.2006.11.007, PII S0021915006006812
    • Ryan, K.E., McCance, D.R., Powell, L., McMahon, R., and Trimble, E.R. (2007). Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men. Atherosclerosis 194, e123-e130 (Pubitemid 47513101)
    • (2007) Atherosclerosis , vol.194 , Issue.2
    • Ryan, K.E.1    McCance, D.R.2    Powell, L.3    McMahon, R.4    Trimble, E.R.5
  • 35
    • 23244468300 scopus 로고    scopus 로고
    • More evidence of cardiorenal protective effects of peroxisome proliferator-activated receptor activation
    • DOI 10.1161/01.HYP.0000172756.41375.e4
    • Schiffrin, E.L. (2005). More evidence of cardiorenal protective effects of peroxisome proliferator-activated receptor activation. Hypertension 46, 267-268 (Pubitemid 41099154)
    • (2005) Hypertension , vol.46 , Issue.2 , pp. 267-268
    • Schiffrin, E.L.1
  • 36
    • 34347350171 scopus 로고    scopus 로고
    • Chronic kidney disease: Effects on the cardiovascular system
    • DOI 10.1161/CIRCULATIONAHA.106.678342, PII 0000301720070703000015
    • Schiffrin, E.L., Lipman, M.L., and Mann, J.F.E. (2007). Chronic kidney disease: effects on the cardiovascular system. Circulation 116, 85-97 (Pubitemid 47016250)
    • (2007) Circulation , vol.116 , Issue.1 , pp. 85-97
    • Schiffrin, E.L.1    Lipman, M.L.2    Mann, J.F.E.3
  • 38
    • 67649397446 scopus 로고    scopus 로고
    • Inflammation in chronic kidney disease: Role in the progression of renal and cardiovascular disease
    • Silverstein, D.M. (2009). Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol 24, 1445-1452
    • (2009) Pediatr. Nephrol. , vol.24 , pp. 1445-1452
    • Silverstein, D.M.1
  • 40
    • 44649141518 scopus 로고    scopus 로고
    • Effect of peroxisome proliferator-activated receptor-α ligands in the interaction between adipocytes and macrophages in obese adipose tissue
    • DOI 10.1038/oby.2008.62, PII OBY200862
    • Toyoda, T., Kamei, Y., Kato, H., Sugita, S., Takeya, M., Suganami, T., et al.. (2008). Effect of peroxisome proliferatoractivated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue. Obesity 16, 1199-1207 (Pubitemid 351771340)
    • (2008) Obesity , vol.16 , Issue.6 , pp. 1199-1207
    • Toyoda, T.1    Kamei, Y.2    Kato, H.3    Sugita, S.4    Takeya, M.5    Suganami, T.6    Ogawa, Y.7
  • 42
    • 34948859481 scopus 로고    scopus 로고
    • The peroxisome proliferator-activated receptor-γ agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance
    • DOI 10.2337/db07-0069
    • Werner, C., Kamani, C.H., Gensch, C., Bohm, M. and Laufs, U. (2007). The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes 56, 2609-2615 (Pubitemid 47523269)
    • (2007) Diabetes , vol.56 , Issue.10 , pp. 2609-2615
    • Werner, C.1    Kamani, C.H.2    Gensch, C.3    Bohm, M.4    Laufs, U.5
  • 43
    • 23244463712 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-α activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade
    • DOI 10.1161/01.HYP.0000172755.25382.fc
    • Williams, J.M., Zhao, X., Wang, M.H., Imig, J.D. and Pollock, D.M. (2005). Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade. Hypertension 46, 366-371 (Pubitemid 41099171)
    • (2005) Hypertension , vol.46 , Issue.2 , pp. 366-371
    • Williams, J.M.1    Zhao, X.2    Wang, M.H.3    Imig, J.D.4    Pollock, D.M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.